Congressional hearings on the Orphan Drug Act

Add some hearings..

1983

Oversight on implementation of the Orphan Drug Act (Public Law 97-414) : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-eighth Congress, first session, on reviewing the radioepidemiological tables and thyroid cancer research (section 7 of the Orphan Drug Act, Public Law 97-414), April 12, 1983. http://catalog.hathitrust.org/Record/011342996

….

1985

FDA issues : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, risks and benefits of raw milk, February 13, 1985; Emergency Reye’s Syndrone Prevention Act of 1985, March 15, 1985; Orphan Drug Act reauthorization, March 20, 1985. http://catalog.hathitrust.org/Record/003491125

An Act to Amend the Orphan Drug Provisions of the Federal Food, Drug, and Cosmetic Act and Related Laws. http://catalog.hathitrust.org/Record/102223410

1990

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.

1991

1992

Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992. http://catalog.hathitrust.org/Record/008517675

Orphan Drug Amendments of 1991 : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2060, Tuesday, March 3, 1992. 4.L 11/4:S.HRG.102-860

1993

1994

Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994. https://catalog.hathitrust.org/Record/003485048

1995

1996